Definitive Contract 75N95022C00004
Award Date
2/22/22
Potential Completion Date
2/21/27
Potential Value
$7.7M
Federal Agency
National Institute on Drug Abuse
Awardee
Virginia Commonwealth University
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Richmond, VA 23284, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,833,141.44 cost-reimbursable contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Virginia Commonwealth University (VCU) for medication discovery research using rat models of drug relapse. The contract has a period of performance from July 10, 2019 to July 9, 2024, with the initial award covering the first year. This contract was awarded under a competitive solicitation that was open to small businesses only, but no...
This is a cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Virginia Commonwealth University (VCU) for $11,354,157.46. The contract is for preclinical medication discovery and abuse liability testing services in support of NIDA's mission. The contract has a period of performance from February 22, 2017 to February 21, 2018, with a potential completion date of February 16, 2025. This award is not...
This is a $7,845,352.00 definitive, cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Virginia Commonwealth University (VCU) for medication discovery research using rat models of relapse. The contract supports NIDA's Addiction Treatment Discovery Program, which aims to identify potential pharmacotherapies to prevent relapse to cocaine and other drug abuse. The work involves developing and utilizing rodent...
This federal contract award is for $126,725.04 and was issued by the Department of Justice Drug Enforcement Administration to the prime contractor, Virginia Commonwealth University (VCU), located in West Springfield, VA. The contract is for study reports and results from the scientific investigation of the in vivo analgesic effects. This is a firm fixed price purchase order with a completion date of November 30, 2019. There is no set-aside designation mentioned for this award. VCU, doing...
This is a $876,368.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Virginia Commonwealth University (VCU), a public research university. The contract is for the in vitro and in vivo assessment of buprenorphine extended release injections to evaluate generic product equivalence. The contract has been modified to extend the period of performance end date to September 29, 2026. VCU is a major recipient of federal contracts and grants, providing...
This is a federal contract award made by the National Institutes of Health (NIH) to Virginia Commonwealth University (VCU), a public research university located in Richmond, Virginia. The $2,109,534 definitive contract is for biomedical research and does not have a set-aside designation. The contract has a period of performance ending on February 28, 2007. VCU has a history of providing educational services, biomedical and clinical research, and technology development support to various...
The Department of Health and Human Services, Food and Drug Administration awarded a firm-fixed price definitive contract to Virginia Commonwealth University (VCU) to evaluate relationships between in vitro nasal spray characterization test metrics for bioequivalence and nasal deposition in silico and in vitro. The contract has a potential value of $1,136,057.48 and a completion date of July 30, 2021. VCU, a public research university located in Richmond, Virginia, has a broad range of federal...
This is a federal contract award to Virginia Commonwealth University (VCU) for biomedical research and services. The contract has a total ceiling value of $247,803.04 and was awarded on April 15, 1999 with a completion date of April 30, 2011. The contract is a definitive contract with a cost no fee pricing type. The contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is a civilian agency under the Department of Health and Human Services....
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Virginia Commonwealth University (VCU) for sample collection services. The contract has a total ceiling value of $59,337.43 and a period of performance ending on March 31, 2022. VCU is a public research university that provides a wide range of services to the federal government, including...
This is a firm fixed-price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Virginia Commonwealth University (VCU) for the collection, processing, and testing of human urine material to support the development of Standard Reference Material (SRM) 3666. The contract has a ceiling value of $75,065 and a period of performance ending on April 30, 2019. There is no set-aside designation for this award. VCU is a public research...